Other investigators have reported that STING stimulation with STING agonists or irradiation improves the tumor microenvironment and sensitivity to EGFR-TKIs and immune checkpoint inhibitors in EGFR-mutated mouse tumor models [41,42,43]. The gene discussed is STING1; the disease is neoplasm.